Sonia Khier

565 total citations
22 papers, 422 citations indexed

About

Sonia Khier is a scholar working on Pharmacology, Organic Chemistry and Surgery. According to data from OpenAlex, Sonia Khier has authored 22 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Organic Chemistry and 4 papers in Surgery. Recurrent topics in Sonia Khier's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Synthesis and Biological Evaluation (5 papers) and Quinazolinone synthesis and applications (3 papers). Sonia Khier is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Synthesis and Biological Evaluation (5 papers) and Quinazolinone synthesis and applications (3 papers). Sonia Khier collaborates with scholars based in France, United States and Switzerland. Sonia Khier's co-authors include David Fabre, Florence Gattacceca, Nassim Djebli, Françoise Bressolle, Carine Deleuze‐Masquéfa, Elisa A. M. Calvier, Frédéric Pinguet, Pierre‐Antoine Bonnet, Christophe Dadure and Xavier Capdevila and has published in prestigious journals such as PLoS ONE, British Journal of Anaesthesia and European Journal of Medicinal Chemistry.

In The Last Decade

Sonia Khier

22 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sonia Khier France	12	116	82	71	57	52	22	422
Carolyn R. Lew United States	14	162 1.4×	101 1.2×	13 0.2×	89 1.6×	18 0.3×	29	471
Xiaofang Wang China	13	118 1.0×	76 0.9×	41 0.6×	76 1.3×	5 0.1×	40	453
Jason M. Gow United States	11	157 1.4×	34 0.4×	59 0.8×	71 1.2×	40 0.8×	12	615
Sara Salerno United States	10	397 3.4×	40 0.5×	34 0.5×	15 0.3×	79 1.5×	19	948
Manon Roche France	10	39 0.3×	78 1.0×	55 0.8×	35 0.6×	6 0.1×	24	402
Bas Thijssen Netherlands	12	138 1.2×	37 0.5×	12 0.2×	17 0.3×	55 1.1×	21	461
Elisa Pirro Italy	12	81 0.7×	53 0.6×	24 0.3×	62 1.1×	52 1.0×	22	437
James Crooks United Kingdom	13	137 1.2×	17 0.2×	34 0.5×	74 1.3×	26 0.5×	29	857
Florent Puisset France	13	106 0.9×	25 0.3×	30 0.4×	26 0.5×	21 0.4×	35	521
Shinichi Miura Japan	15	202 1.7×	21 0.3×	30 0.4×	84 1.5×	53 1.0×	32	735

Countries citing papers authored by Sonia Khier

Since Specialization

Citations

This map shows the geographic impact of Sonia Khier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonia Khier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonia Khier more than expected).

Fields of papers citing papers by Sonia Khier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonia Khier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonia Khier. The network helps show where Sonia Khier may publish in the future.

Co-authorship network of co-authors of Sonia Khier

This figure shows the co-authorship network connecting the top 25 collaborators of Sonia Khier. A scholar is included among the top collaborators of Sonia Khier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonia Khier. Sonia Khier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khier, Sonia, David Fabre, Jérôme Azé, et al.. (2025). Covariate Model Selection Approaches for Population Pharmacokinetics: A Systematic Review of Existing Methods, From SCM to AI. CPT Pharmacometrics & Systems Pharmacology. 14(4). 621–639. 1 indexed citations

Abla, Nada, Elodie Jambert, Stephan Duparc, et al.. (2024). Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure. Malaria Journal. 23(1). 287–287. 2 indexed citations

Khier, Sonia, Youssef Daali, Michael Medinger, et al.. (2023). Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT. Transplantation and Cellular Therapy. 30(3). 332.e1–332.e15. 4 indexed citations

Santoro, Lore, et al.. (2023). Clinical Pharmacokinetics of Radiopharmaceuticals from SPECT/CT Image Acquisition by Contouring in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Lu-177 DOTATATE (Lutathera®) Case. European Journal of Drug Metabolism and Pharmacokinetics. 48(4). 329–339. 1 indexed citations

Djebli, Nassim, et al.. (2022). Combined Semi-mechanistic Target-Mediated Drug Disposition and Pharmacokinetic–Pharmacodynamic Models of Alirocumab, PCSK9, and Low-Density Lipoprotein Cholesterol in a Pooled Analysis of Randomized Phase I/II/III Studies. European Journal of Drug Metabolism and Pharmacokinetics. 47(6). 789–802. 1 indexed citations

Khier, Sonia & Peter B. Gahan. (2021). Hepatic Clearance of Cell-Free DNA: Possible Impact on Early Metastasis Diagnosis. Molecular Diagnosis & Therapy. 25(6). 677–682. 11 indexed citations

Larcher, Romaric, et al.. (2021). Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Patients: How to Achieve Best Dosage Regimen According to the Clinical Situation. European Journal of Drug Metabolism and Pharmacokinetics. 46(5). 695–705. 14 indexed citations

Meunier, Lucy, et al.. (2021). Can We Predict Individual Concentrations of Tacrolimus After Liver Transplantation? Application and Tweaking of a Published Population Pharmacokinetic Model in Clinical Practice. Therapeutic Drug Monitoring. 43(4). 490–498. 7 indexed citations

Khier, Sonia, et al.. (2021). Model-Informed Therapeutic Drug Monitoring of Meropenem in Critically Ill Patients: Improvement of the Predictive Ability of Literature Models with the PRIOR Approach. European Journal of Drug Metabolism and Pharmacokinetics. 46(3). 415–426. 8 indexed citations

10.

Calvier, Elisa A. M., et al.. (2020). Prior information for population pharmacokinetic and pharmacokinetic/pharmacodynamic analysis: overview and guidance with a focus on the NONMEM PRIOR subroutine. Journal of Pharmacokinetics and Pharmacodynamics. 47(5). 431–446. 49 indexed citations

11.

Vincent, Marc, et al.. (2019). Population Pharmacokinetics of Levobupivacaine During Transversus Abdominis Plane Block in Children. Therapeutic Drug Monitoring. 42(3). 497–502. 5 indexed citations

12.

Djebli, Nassim, et al.. (2017). Target-Mediated Drug Disposition Population Pharmacokinetics Model of Alirocumab in Healthy Volunteers and Patients: Pooled Analysis of Randomized Phase I/II/III Studies. Clinical Pharmacokinetics. 56(10). 1155–1171. 24 indexed citations

13.

Courbet, Alexis, Nicole Bec, Christian Larroque, et al.. (2017). Imidazoquinoxaline anticancer derivatives and imiquimod interact with tubulin: Characterization of molecular microtubule inhibiting mechanisms in correlation with cytotoxicity. PLoS ONE. 12(8). e0182022–e0182022. 20 indexed citations

14.

Djebli, Nassim, et al.. (2016). Ocular Drug Distribution After Topical Administration: Population Pharmacokinetic Model in Rabbits. European Journal of Drug Metabolism and Pharmacokinetics. 42(1). 59–68. 41 indexed citations

15.

Khier, Sonia, et al.. (2014). Population pharmacokinetic analysis of fexofenadine in Japanese pediatric patients. Journal of Pharmacokinetics and Pharmacodynamics. 41(2). 187–195. 6 indexed citations

16.

Khier, Sonia, et al.. (2011). Population pharmacokinetics of nalbuphine after surgery in children. British Journal of Anaesthesia. 106(4). 558–565. 27 indexed citations

17.

Khier, Sonia, Florence Gattacceca, Safia El Messaoudi, et al.. (2010). Metabolism and Pharmacokinetics of EAPB0203 and EAPB0503, Two Imidazoquinoxaline Compounds Previously Shown to Have Antitumoral Activity on Melanoma and T-Lymphomas. Drug Metabolism and Disposition. 38(10). 1836–1847. 12 indexed citations

18.

Khier, Sonia, Carine Deleuze‐Masquéfa, Georges Moarbess, et al.. (2009). Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma. European Journal of Pharmaceutical Sciences. 39(1-3). 23–29. 22 indexed citations

19.

Deleuze‐Masquéfa, Carine, Georges Moarbess, Sonia Khier, et al.. (2009). New imidazo[1,2-a]quinoxaline derivatives: Synthesis and in vitro activity against human melanoma. European Journal of Medicinal Chemistry. 44(9). 3406–3411. 37 indexed citations

20.

Bressolle, Françoise, et al.. (2009). Population pharmacokinetics of the two enantiomers of tramadol and O-demethyl tramadol after surgery in children. British Journal of Anaesthesia. 102(3). 390–399. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact